News | February 25, 2009

RTOG Elects Full Member Principal Investigators Chair

February 25, 2009 – The Radiation Therapy Oncology Group (RTOG) has elected Elizabeth M. Gore, M.D. chair of the Full Member Principal Investigators Committee.

Dr. Gore is the RTOG principal investigator for the Medical College of Wisconsin in Milwaukee, where she is an associate professor of radiation oncology. RTOG is a National Cancer Institute-funded national clinical trials group and is administered by the American College of Radiology.

“Dr. Gore is the principal investigator for one our most productive member institutions. She has been very active in RTOG research as a protocol chair and a member of our Lung Cancer Committee,” said Walter J. Curran, Jr., M.D., the RTOG Group Chair, and the Lawrence W. Davis Professor and Chair of the Department of Radiation Oncology in the Emory School of Medicine and Chief Medical Officer of the Emory Winship Cancer Institute. “She has made significant contributions to the group’s research mission and, in recognition of her commitment, the RTOG leadership named Dr. Gore to our inaugural class of RTOG Next Generation Investigators last spring.”

“I am honored to be elected by my fellow full member principal investigators to this position,” said Dr. Gore. “The full member institutions are the backbone of the group, helping to define its scientific mission and responsible for the majority of its accrual. I plan to work closely with the RTOG leadership, the Membership Committee, and headquarters’ staff to address our concerns about accrual, data submission, and reimbursement issues. Our goal is to help the full members improve their RTOG experience which will hopefully translate into increased accrual enhancing the group’s ability to complete protocols quickly.”

As the chair of the RTOG Full Member Principal Investigators Committee, Dr. Gore will serve on the RTOG Executive and Steering Committees representing the interests of the full member institutions and she will also chair the RTOG Bylaws Committee. Dr. Gore is the first investigator elected to this newly created position.

The Medical College of Wisconsin has been an RTOG member for over 30 years. In addition to her research and teaching responsibilities, Dr. Gore practices at the Zablocki VA Medical Center –Milwaukee, a major hospital affiliate of the College.

Source: The Radiation Therapy Oncology Group (RTOG) and the American College of Radiology (ACR)

For more information:

Related Content

First Hospitals Achieve Inter-System Connectivity Across Accuray Radiation Therapy Platforms
News | Radiation Therapy | January 19, 2018
Accuray Inc. announced recently that the Heidelberg University Hospital in Heidelberg, Germany, and Oscar Lambret...
RayStation Selected for New Carbon Ion Therapy Center in Japan
News | Treatment Planning | January 18, 2018
January 18, 2018 – RayStation has been chosen as the treatment planning system for a new carbon-ion therapy facility
Raysearch Receives First Order for the Raycare Oncology Information System
News | Oncology Information Management Systems (OIMS) | January 18, 2018
January 18, 2018 – Anderson Regional Cancer Center (ARCC) in Meridian, Mississippi, has placed the first order for...
Mevion Receives 510(k) Clearance for Hyperscan Pencil Beam Scanning Proton Therapy
Technology | Proton Therapy | January 04, 2018
Mevion Medical Systems has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Mevion S250i...
Study Compares Radiosurgery and Whole-Brain Radiation in Lung Cancer Patients With Multiple Brain Metastases
News | Radiation Therapy | January 03, 2018
Although targeted therapies have produced dramatic advances in the ability to control some types of advanced lung...
MEDraysintell Downgrades Proton Therapy Market Projection for 2030
News | Proton Therapy | January 02, 2018
MEDraysintell recently downgraded its projection for proton therapy rooms expected to be operational in 2030 from 1,200...
California US Oncology Network Centers Adopt Xoft Electronic Brachytherapy System for Early-Stage Non-Melanoma Skin Cancer
News | Brachytherapy Systems | January 02, 2018
iCAD Inc. announced that its Xoft Axxent Electronic Brachytherapy (eBx) System is now available at two California-based...
Blue Phantom System Used for Acceptance of First European Varian Halcyon Machine
News | Radiation Therapy | January 02, 2018
IBA (Ion Beam Applications S.A.) announced in November the acceptance and beam model validation of the first Varian...
Study Finds Link Between Breast Cancer Treatments and Cellular Aging Markers
News | Women's Health | January 02, 2018
January 2, 2018 — A new study found women who had received chemotherapy and/or...
ACR Appropriateness Criteria Adds and Revises Topics for December 2017
News | Clinical Decision Support | December 29, 2017
December 29, 2017 — Radiologists can enhance the quality and effectiveness of care with the newest release of the ACR
Overlay Init